High-Risk Chronic Lymphocytic Leukemia in a Young Adult Filipino Female treated with Reduced-dosage, Fixed-duration Ibrutinib and Venetoclax: A Case Report Caryn Louise D. Gutierrez, MD, Anne Kristine H. Quero-Taggaoa, MD, Timothy Carl F. Uy, MD, Januario Antonio D. Veloso, Jr., MD Contact: cmdemesa@up.edu.ph